3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Wounds and Injuries
1
Trauma, Nervous System
1
Stress Disorders, Post-Traumatic
1
Neoplasms
1
Depression
1
Interventions
Cisplatin
15
Paclitaxel
14
Taxes
10
Cyclophosphamide
9
Carboplatin
9
Gemcitabine
7
Platinum
6
1,2-diaminocyclohexaneplatinum II citrate
6
Trastuzumab
5
Radiotherapy
5
Oxaliplatin
5
Doxorubicin
5
Docetaxel
5
Cytarabine
5
Capecitabine
5
Brachytherapy
5
fludarabine
4
Rituximab
4
Radiotherapy, Intensity-Modulated
4
Radiosurgery
4
Fluorouracil
4
Dexamethasone
4
Watchful Waiting
3
Radiotherapy, Conformal
3
Pemetrexed
3
Nimorazole
3
Lenalidomide
3
Imatinib Mesylate
3
Idarubicin
3
Gene Expression Profiling
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
NETWORK
×
Psilocybin
×
Clear all
NCT05042466
2022-11-16
NWTTPS
NWTraumatherapies
Phase 1
Unknown
30 enrolled